FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Moving to a Shared Services and Inspections Approach

[ Price : $8.95]

NOTUS reports that FDA will reorganize on 10/1 to a shared services model in which administrative functions are centralized, and i...

Controlled Evidence Ecosystem Needed: Expert Column

[ Price : $8.95]

A BioProcess International column says drug companies should design a controlled evidence ecosystem that can demonstrate to FDA in...

Reviewers Concerned About Data Supporting Replimune Melanoma BLA

[ Price : $8.95]

FDA reviewers raise concerns about the clinical evidence supporting Replimune Group's BLA resubmission for accelerated approval of...

Linemaster Switch QS Violations

[ Price : $8.95]

FDA warns Woodstock, CT-based Linemaster Switch Corp. about Quality System violations in its production of medical device foot ped...

FDA: VasoCorp Selling Unapproved, Misbranded Drugs

[ Price : $8.95]

FDA warns Hiram, GA-based VasoCorp Inc. that it is illegally marketing misbranded unapproved new drugs.

PhRMA Urges FDA to Clarify Drug Dose Modeling Guidance

[ Price : $8.95]

The Pharmaceutical Research and Manufacturers of America urges FDA to revise and clarify its draft guidance on using quantitative ...

Alkem Labs Plant in India Cited Over OOS Investigations, Quality Systems

[ Price : $8.95]

FDA issues a 26-page Form 483 to Alkem Laboratories following an 4/20-5/1 inspection of the company's finished drug manufacturing ...

17 Revised Draft Guidances for Certain Generic Peptide Products

[ Price : $8.95]

FDA posts 17 revised draft product-specific guidances for peptide products, which it touts as a significant advancement in the age...

Novo Nordisk Seeks Preliminary Injunction Against Lilly

[ Price : $8.95]

Novo Nordisk intensifies pressure against Eli Lilly under a motion seeking a preliminary injunction to stop Eli Lilly's misleading...

CBER Offers Tips for Cell/Gene Therapy BLA Submissions

[ Price : $8.95]

CBER recently used a virtual town hall to urge developers of cell and gene therapies to take advantage of early engagements with t...